1 – 53 of 53
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
2024) In Haemophilia(
- Contribution to journal › Article
- 2023
-
Mark
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B : post hoc analysis of phase III trials using patient-reported outcomes
(
- Contribution to journal › Article
- 2022
-
Mark
rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B : Post hoc analysis of B-LONG using haemophilia-specific quality of life questionnaires
(
- Contribution to journal › Article
- 2018
-
Mark
How I manage patients with inherited haemophilia A and B and factor inhibitors
(
- Contribution to journal › Scientific review
- 2017
-
Mark
European retrospective study of real-life haemophilia treatment
(
- Contribution to journal › Article
-
Mark
Primary prophylaxis in haemophilia care : Guideline update 2016
(
- Contribution to journal › Article
-
Mark
Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment
(
- Contribution to journal › Article
- 2016
-
Mark
Future of haemophilia outcome assessment : Registries are key to optimized treatment
(
- Contribution to journal › Article
-
Mark
Measuring factor IX activity of nonacog beta pegol with commercially available one-stage clotting and chromogenic assay kits : A two-center study
(
- Contribution to journal › Article
-
Mark
Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products
(
- Contribution to journal › Article
-
Mark
Aspects of prophylactic treatment of hemophilia
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Haemophilia in Sweden – Studies on mutations and clinical implications
(
- Thesis › Doctoral thesis (compilation)
- 2014
-
Mark
Textbook of hemophilia : Care of the child with hemophilia
2014) p.145-150(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Origin of Swedish hemophilia B mutations
(
- Contribution to journal › Article
-
Mark
Progressive improvement in wound healing with increased therapy in haemophilia B mice
(
- Contribution to journal › Article
- 2010
-
Mark
The role of prophylaxis in bleeding disorders
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Management of carriers and babies with haemophilia
(
- Contribution to journal › Article
-
Mark
Plasma-derived biological medicines used to promote haemostasis
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Prevention of bleeding in haemophilia: trends, overcoming barriers and future treatment options
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting.
(
- Contribution to journal › Article
-
Mark
MRI assessment of haemophilic arthropathy
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The risk associated with indwelling catheters in children with haemophilia.
(
- Contribution to journal › Scientific review
- 2006
-
Mark
Functional Analysis of the Factor IX Epidermal Growth Factor-Like Domain Mutation Ile66Thr Associated with Mild Hemophilia B.
(
- Contribution to journal › Article
- 2005
-
Mark
Changing pattern of care of boys with haemophilia in western European centres
(
- Contribution to journal › Article
- 2004
-
Mark
A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia
(
- Contribution to journal › Article
- 2003
-
Mark
HEMOPHILIA A AND B WITH SPECIAL REFERENCE TO INHIBITOR DEVELOPMENT AND EXPERIMENTAL STUDIES OF FACTORS VIII AND IX
2003)(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Inhibitors in the Swedish population with severe haemophilia A and B : A 20-year survey
(
- Contribution to journal › Article
-
Mark
Role of the N-terminal EGF module of coagulation factor IX in activation of factors IX and X.
(
- Contribution to journal › Article
- 2001
-
Mark
Haemophilia B mutations in Sweden: a population-based study of mutational heterogeneity
(
- Contribution to journal › Article
- 2000
-
Mark
Treatment of children with haemophilia in Europe: A survey of 20 centres in 16 countries
(
- Contribution to journal › Article
- 1999
-
Mark
Tolerance induction using the Malmo treatment model 1982-1995
(
- Contribution to journal › Article
-
Mark
Haemophilia B carrier detection by factor IX:C analysis; no impact of the type of mutation or severity of disorder
(
- Contribution to journal › Article
-
Mark
Prenatal diagnosis of haemophilia
(
- Contribution to journal › Scientific review
- 1998
-
Mark
The Malmo-Klaipeda WFH twinning programme: a comparative description of the haemophilia cohorts
(
- Contribution to journal › Scientific review
-
Mark
Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis
(
- Contribution to journal › Article
-
Mark
Immunoadsorption for removal of inhibitors: update on treatments in Malmo-Lund between 1980 and 1995
(
- Contribution to journal › Article
-
Mark
Prophylactic treatment in Sweden - Overtreatment or optimal model?
(
- Contribution to journal › Article
-
Mark
Can haemophilic arthropathy be prevented?
(
- Contribution to journal › Special issue (editor)
-
Mark
Port-A-Cath usage in children with haemophilia : Experience of 53 cases
(
- Contribution to journal › Article
- 1997
-
Mark
No effect of a new second-generation B-domain-deleted recombinant product on lymphocyte transformation in vitro: a study of plasma-derived and recombinant products
(
- Contribution to journal › Article
-
Mark
Pharmacokinetic dosing of factor VIII and factor IX in prophylactic treatment of haemophilia
1997)(
- Thesis › Doctoral thesis (compilation)
- 1995
-
Mark
Gene mutations and inhibitor formation in patients with hemophilia B
(
- Contribution to journal › Article
-
Mark
The impact of prenatal diagnosis on the incidence of haemophilia in Sweden
(
- Contribution to journal › Article
- 1993
-
Mark
Haemophilia : strategies for carrier detection and prenatal diagnosis
(
- Contribution to journal › Article
- 1992
-
Mark
Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia
(
- Contribution to journal › Article
- 1991
-
Mark
Population genetics of the Malmö polymorphism of coagulation factor IX
(
- Contribution to journal › Article
- 1990
-
Mark
The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots
(
- Contribution to journal › Article
-
Mark
Two factor IX mutations in the family of an isolated haemophilia B patient : direct carrier diagnosis by amplification mismatch detection (AMD)
(
- Contribution to journal › Article
-
Mark
Diagnostic symptoms of severe and moderate haemophilia A and B. A survey of 140 cases
(
- Contribution to journal › Article
- 1983
-
Mark
Detection of factor IX inhibitors by immunoradiometric assay
(
- Contribution to journal › Article
- 1982
-
Mark
Haemophilia A and B--two years experience of genetic counselling and prenatal diagnosis
(
- Contribution to journal › Article
-
Mark
Genetic variants of haemophilia B detected by immunoradiometric assay : implications for prenatal diagnosis
(
- Contribution to journal › Article
- 1980
-
Mark
Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX
(
- Contribution to journal › Article